SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-033420
Filing Date
2006-05-10
Accepted
2006-05-10 17:14:50
Documents
13
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-9708_110q.htm 10-Q 423787
2 EX-10 a06-9708_1ex10d1.htm EX-10.1 15736
3 EX-10 a06-9708_1ex10d2.htm EX-10.2 74399
4 EX-10 a06-9708_1ex10d3.htm EX-10.3 74321
5 EX-10 a06-9708_1ex10d4.htm EX-10.4 5968
6 EX-10 a06-9708_1ex10d5.htm EX-10.5 5924
7 EX-10 a06-9708_1ex10d6.htm EX-10.6 49176
8 EX-10 a06-9708_1ex10d7.htm EX-10.7 56382
9 EX-10 a06-9708_1ex10d8.htm EX-10.8 9544
10 EX-10 a06-9708_1ex10d9.htm EX-10.9 8339
11 EX-31 a06-9708_1ex31d1.htm EX-31.1 9073
12 EX-31 a06-9708_1ex31d2.htm EX-31.2 9006
13 EX-32 a06-9708_1ex32d1.htm EX-32.1 5629
  Complete submission text file 0001104659-06-033420.txt   748839
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32715 | Film No.: 06827321
SIC: 2835 In Vitro & In Vivo Diagnostic Substances